It is a pleasure and a privilege to address the readership of Blood in my new capacity as director of the National Heart, Lung, and Blood Institute. Our institute has a long and distinguished record of scientific progress in cardiovascular, lung, and blood diseases and sleep disorders, and the present transition affords an opportunity for reflection and critical assessment of our future directions.
For more information, please view:
Blood, 15 July 2005, Vol. 106, No. 2, pp. 399-400. To obtain a copy, contact the NHLBI Office of Communications at email@example.com or 301-496-4236.